EP1248631A4 - Methods for inhibiting/treating hiv infections and aids related symptoms - Google Patents
Methods for inhibiting/treating hiv infections and aids related symptomsInfo
- Publication number
- EP1248631A4 EP1248631A4 EP01901750A EP01901750A EP1248631A4 EP 1248631 A4 EP1248631 A4 EP 1248631A4 EP 01901750 A EP01901750 A EP 01901750A EP 01901750 A EP01901750 A EP 01901750A EP 1248631 A4 EP1248631 A4 EP 1248631A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- inhibiting
- methods
- related symptoms
- treating hiv
- hiv infections
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
- C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- AIDS & HIV (AREA)
- Public Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17466800P | 2000-01-06 | 2000-01-06 | |
US174668P | 2000-01-06 | ||
PCT/US2001/000280 WO2001049297A1 (en) | 2000-01-06 | 2001-01-05 | Methods for inhibiting/treating hiv infections and aids related symptoms |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1248631A1 EP1248631A1 (en) | 2002-10-16 |
EP1248631A4 true EP1248631A4 (en) | 2003-05-28 |
Family
ID=22637045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP01901750A Withdrawn EP1248631A4 (en) | 2000-01-06 | 2001-01-05 | Methods for inhibiting/treating hiv infections and aids related symptoms |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1248631A4 (en) |
AU (1) | AU2761901A (en) |
CA (1) | CA2396240A1 (en) |
WO (1) | WO2001049297A1 (en) |
-
2001
- 2001-01-05 EP EP01901750A patent/EP1248631A4/en not_active Withdrawn
- 2001-01-05 CA CA002396240A patent/CA2396240A1/en not_active Abandoned
- 2001-01-05 AU AU27619/01A patent/AU2761901A/en not_active Abandoned
- 2001-01-05 WO PCT/US2001/000280 patent/WO2001049297A1/en not_active Application Discontinuation
Non-Patent Citations (2)
Title |
---|
No further relevant documents disclosed * |
See also references of WO0149297A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO2001049297A8 (en) | 2002-02-07 |
EP1248631A1 (en) | 2002-10-16 |
WO2001049297A1 (en) | 2001-07-12 |
CA2396240A1 (en) | 2001-07-12 |
AU2761901A (en) | 2001-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0028269D0 (en) | Well treatment | |
TW574392B (en) | Physical vapor deposition device and method | |
AU3408801A (en) | Tnf-alpha inhibitors | |
HK1054036A1 (en) | Substituted 3-phenyl-5-alkoxi-1, 3, 4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase | |
PL362855A1 (en) | Improved treatment | |
EP1337208A4 (en) | Methods and devices for treating stuttering problems | |
EP1337255A4 (en) | Use of p38 inhibitors for the treatment of inflammation-enhanced cough | |
IL160010A0 (en) | Methods and compositions for treating fungal infections | |
AU2001269704A1 (en) | Oxazinoquinolones useful for the treatment of viral infections | |
AU6387401A (en) | Pyrrole derivatives for treating aids | |
GB9930061D0 (en) | Quinolone compounds for use in treating viral infections | |
AU2002242096A1 (en) | Novel compounds and methods for inhibiting/treating hiv infections and aids related symptoms | |
AU2002365168A8 (en) | Method and composition for treating and preventing hiv infection and aids | |
MXPA03005526A (en) | Combination method for treating viral infections. | |
GB0014580D0 (en) | Appatarus and process | |
EP1248631A4 (en) | Methods for inhibiting/treating hiv infections and aids related symptoms | |
AU2002221760A1 (en) | Vaccine for treating allergy | |
HK1046848A1 (en) | Specific therapeutic composition for treating aids | |
AU2001258675A1 (en) | Treating infections | |
AU2002360523A8 (en) | Compounds to treat hiv infection and aids | |
AU2001288870A1 (en) | Antiviral compounds and method of treating viral infections | |
GB0031321D0 (en) | Treatment | |
AU2697401A (en) | Medicament and method for treating sclerotinia infections | |
TW479626U (en) | Treatment device for junk | |
EP1303281A4 (en) | Methods of treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20020729 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20030411 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7C 07H 21/02 B Ipc: 7C 07H 21/04 B Ipc: 7A 61K 31/70 A Ipc: 7C 07H 21/00 B |
|
17Q | First examination report despatched |
Effective date: 20040617 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20051125 |